免疫检查点阻断通过扩增效应 CD8⁺ T 细胞克隆增强淋巴细胞清除性化疗诱导的抗肿瘤免疫
Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy-Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Identification of two distinct uveal melanoma subtypes based on the immune cell infiltration of the primary tumour.
Identification of two distinct uveal melanoma subtypes based on the immune cell infiltration of the primary tumour.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
我们的研究揭示了原发性 UM 肿瘤内的细胞和免疫异质性。识别出免疫学上不同的肿瘤类型,以及侵袭性黑色素细胞亚群和基质相互作用,为 UM 发病机制提供了见解,并支持分层免疫治疗策略。
葡萄膜黑色素瘤(UM)是最常见的眼内恶性肿瘤,转移性病例预后差,对常规治疗反应有限。尽管在遗传分层方面取得了进展,但原发性UM的免疫学特征仍知之甚少。
原发性1类和2类(BAP1缺失)UM肿瘤的单细胞RNA测序(scRNA-seq)二次数据生成,以及对8例原发性UM肿瘤活检组织的流式细胞术分析,被用于表征与肿瘤进展和免疫浸润相关的肿瘤微环境、细胞组成、肿瘤-免疫细胞相互作用以及基质标志物表达。
scRNA-seq分析揭示了16个不同的细胞簇,包括黑色素瘤细胞、T细胞、巨噬细胞和基质细胞。Class 2肿瘤包含独特的黑色素瘤细胞亚群,表现出8号染色体拷贝数变异,并富集于缺氧、PI3K-Akt和MAPK信号通路。配体-受体分析发现这些侵袭性黑色素瘤细胞与周细胞/巨噬细胞之间存在广泛的相互作用。流式细胞术分析确认了两种不同的免疫浸润特征:以CD14⁺细胞为主的低浸润肿瘤,以及具有表达PD-1和CD27的CD8⁺记忆样T细胞的高浸润肿瘤。基质标志物分析显示,免疫排斥肿瘤中CD81和NGFR表达升高,提示它们与转移潜能相关。
Uveal melanoma (UM) is the most common intraocular malignancy, with poor prognosis in metastatic cases and limited response to conventional therapies. Despite advances in genetic stratification, the immunological landscape of primary UM remains poorly understood.
Secondary data generation of single-cell RNA sequencing (scRNA-seq) of primary class 1 and class 2 (loss of BAP1) UM tumours and flow cytometric analysis of 8 primary UM tumour biopsies were used to characterize the tumour microenvironment, cellular composition, tumour-immune cell interactions, and stromal marker expression associated with tumour progression and immune infiltration.
scRNA-seq analysis revealed 16 distinct cell clusters, including melanocytes, T cells, macrophages, and stromal cells. Class 2 tumours contained unique melanocyte subpopulations exhibiting chromosome 8 copy number variations and enriched in hypoxia, PI3K-Akt, and MAPK signalling pathways. Ligand-receptor analysis identified extensive interactions between these aggressive melanocytes and pericytes/macrophages. Flow cytometric analysis confirmed two distinct immune infiltrate profiles: low-infiltrate tumours dominated by CD14⁺ cells, and high-infiltrate tumours with CD8⁺ memory-like T cells expressing PD-1 and CD27. Stromal marker analysis revealed elevated expression of CD81 and NGFR in immune-excluded tumours, implicating them in metastatic potential.
Our study reveals cellular and immunological heterogeneity within primary UM tumours. The identification of immunologically distinct tumour types, along with aggressive melanocyte subpopulations and stromal interactions, provides insight into UM pathogenesis and supports stratified immunotherapeutic approaches.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。